

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 6.79680993 |
| 2 | purine nucleobase biosynthetic process (GO:0009113) | 6.31799948 |
| 3 | ribosome assembly (GO:0042255) | 6.07490503 |
| 4 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 5.66048105 |
| 5 | termination of RNA polymerase III transcription (GO:0006386) | 5.66048105 |
| 6 | nucleobase biosynthetic process (GO:0046112) | 5.37538955 |
| 7 | rRNA modification (GO:0000154) | 5.29011614 |
| 8 | DNA deamination (GO:0045006) | 5.20726791 |
| 9 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 5.20459763 |
| 10 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 5.12917187 |
| 11 | 7-methylguanosine mRNA capping (GO:0006370) | 5.10014006 |
| 12 | amino acid salvage (GO:0043102) | 5.06581909 |
| 13 | L-methionine salvage (GO:0071267) | 5.06581909 |
| 14 | L-methionine biosynthetic process (GO:0071265) | 5.06581909 |
| 15 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 5.02481395 |
| 16 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 5.00942413 |
| 17 | 7-methylguanosine RNA capping (GO:0009452) | 4.93526567 |
| 18 | RNA capping (GO:0036260) | 4.93526567 |
| 19 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.71474201 |
| 20 | ribosome biogenesis (GO:0042254) | 4.70534803 |
| 21 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.66051911 |
| 22 | synaptic vesicle maturation (GO:0016188) | 4.64732092 |
| 23 | negative regulation of ligase activity (GO:0051352) | 4.57726454 |
| 24 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.57726454 |
| 25 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 4.55585787 |
| 26 | folic acid transport (GO:0015884) | 4.55173231 |
| 27 | positive regulation of mitochondrial fission (GO:0090141) | 4.53803150 |
| 28 | transcription from RNA polymerase I promoter (GO:0006360) | 4.53248936 |
| 29 | termination of RNA polymerase I transcription (GO:0006363) | 4.47609695 |
| 30 | positive regulation of ligase activity (GO:0051351) | 4.38510920 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.34774861 |
| 32 | regulation of mitochondrial translation (GO:0070129) | 4.26042991 |
| 33 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.23747387 |
| 34 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.23361830 |
| 35 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.23361830 |
| 36 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.23361830 |
| 37 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.21461198 |
| 38 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.21461198 |
| 39 | blastocyst development (GO:0001824) | 4.20445107 |
| 40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.17949697 |
| 41 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.17304689 |
| 42 | synaptic vesicle exocytosis (GO:0016079) | 4.17262060 |
| 43 | mitotic metaphase plate congression (GO:0007080) | 4.09762440 |
| 44 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.08480480 |
| 45 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.08480480 |
| 46 | folic acid metabolic process (GO:0046655) | 4.05299595 |
| 47 | lung-associated mesenchyme development (GO:0060484) | 4.00772663 |
| 48 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.99952719 |
| 49 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.96822255 |
| 50 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.96556479 |
| 51 | NADH metabolic process (GO:0006734) | 3.94918042 |
| 52 | glutamate secretion (GO:0014047) | 3.86319336 |
| 53 | methionine biosynthetic process (GO:0009086) | 3.84351248 |
| 54 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.82265803 |
| 55 | regulation of synaptic vesicle transport (GO:1902803) | 3.78542338 |
| 56 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.77197599 |
| 57 | regulation of ligase activity (GO:0051340) | 3.76450705 |
| 58 | formation of translation preinitiation complex (GO:0001731) | 3.75386822 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.72199809 |
| 60 | GMP metabolic process (GO:0046037) | 3.71095344 |
| 61 | intestinal epithelial cell development (GO:0060576) | 3.70824502 |
| 62 | DNA-templated transcription, elongation (GO:0006354) | 3.70428917 |
| 63 | methionine metabolic process (GO:0006555) | 3.63250146 |
| 64 | rRNA methylation (GO:0031167) | 3.60138117 |
| 65 | maturation of 5.8S rRNA (GO:0000460) | 3.59011417 |
| 66 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.58753951 |
| 67 | positive regulation of viral transcription (GO:0050434) | 3.58405210 |
| 68 | regulation of translation in response to stress (GO:0043555) | 3.55793482 |
| 69 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.54085678 |
| 70 | protein targeting to mitochondrion (GO:0006626) | 3.51964684 |
| 71 | autophagic vacuole assembly (GO:0000045) | 3.49749879 |
| 72 | regulation of G0 to G1 transition (GO:0070316) | 3.49640098 |
| 73 | maturation of SSU-rRNA (GO:0030490) | 3.49475659 |
| 74 | establishment of protein localization to mitochondrion (GO:0072655) | 3.48125898 |
| 75 | DNA replication checkpoint (GO:0000076) | 3.47308972 |
| 76 | rRNA processing (GO:0006364) | 3.47254498 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.45690185 |
| 78 | ribosomal large subunit biogenesis (GO:0042273) | 3.45438058 |
| 79 | regulation of cellular amine metabolic process (GO:0033238) | 3.45207345 |
| 80 | protein neddylation (GO:0045116) | 3.44413788 |
| 81 | vitamin transmembrane transport (GO:0035461) | 3.44106189 |
| 82 | spliceosomal snRNP assembly (GO:0000387) | 3.43996097 |
| 83 | cullin deneddylation (GO:0010388) | 3.40826003 |
| 84 | polyamine biosynthetic process (GO:0006596) | 3.40228828 |
| 85 | positive regulation of cell cycle arrest (GO:0071158) | 3.38563221 |
| 86 | rRNA metabolic process (GO:0016072) | 3.35040577 |
| 87 | neuronal action potential propagation (GO:0019227) | 3.34155720 |
| 88 | negative regulation of macroautophagy (GO:0016242) | 3.31495330 |
| 89 | protein localization to mitochondrion (GO:0070585) | 3.30732282 |
| 90 | response to xenobiotic stimulus (GO:0009410) | 3.29650838 |
| 91 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.27799945 |
| 92 | cell cycle G1/S phase transition (GO:0044843) | 3.27799945 |
| 93 | cellular component biogenesis (GO:0044085) | 3.27322988 |
| 94 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.27139209 |
| 95 | GDP-mannose metabolic process (GO:0019673) | 3.27067860 |
| 96 | protein deneddylation (GO:0000338) | 3.26405829 |
| 97 | S-adenosylmethionine metabolic process (GO:0046500) | 3.25491690 |
| 98 | regulation of spindle organization (GO:0090224) | 3.23360179 |
| 99 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.20627057 |
| 100 | negative regulation of protein ubiquitination (GO:0031397) | 3.19530615 |
| 101 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.18548583 |
| 102 | peptidyl-histidine modification (GO:0018202) | 3.17987838 |
| 103 | chaperone-mediated protein transport (GO:0072321) | 3.17384139 |
| 104 | amino sugar catabolic process (GO:0046348) | 3.17146226 |
| 105 | pseudouridine synthesis (GO:0001522) | 3.14566356 |
| 106 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.12643535 |
| 107 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.12643535 |
| 108 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.10380609 |
| 109 | polyamine metabolic process (GO:0006595) | 3.09659128 |
| 110 | regulation of mitochondrial fission (GO:0090140) | 3.06962595 |
| 111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.06501109 |
| 112 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.05059940 |
| 113 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.05059940 |
| 114 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04224957 |
| 115 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.03948314 |
| 116 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 3.03504179 |
| 117 | sulfur amino acid biosynthetic process (GO:0000097) | 3.02681301 |
| 118 | transcription from RNA polymerase III promoter (GO:0006383) | 3.01556928 |
| 119 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.00799409 |
| 120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93645346 |
| 121 | neurotransmitter secretion (GO:0007269) | 2.91064511 |
| 122 | negative regulation of heart rate (GO:0010459) | 2.90852719 |
| 123 | regulation of synapse structural plasticity (GO:0051823) | 2.89260016 |
| 124 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.86635248 |
| 125 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.86477016 |
| 126 | COPI coating of Golgi vesicle (GO:0048205) | 2.84664390 |
| 127 | Golgi transport vesicle coating (GO:0048200) | 2.84664390 |
| 128 | transferrin transport (GO:0033572) | 2.82769707 |
| 129 | viral protein processing (GO:0019082) | 2.76359717 |
| 130 | negative regulation of cation channel activity (GO:2001258) | 2.74652930 |
| 131 | organelle transport along microtubule (GO:0072384) | 2.74515168 |
| 132 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.68100469 |
| 133 | glycerophospholipid catabolic process (GO:0046475) | 2.66624487 |
| 134 | establishment of mitochondrion localization (GO:0051654) | 2.64949082 |
| 135 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.63993977 |
| 136 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.63993977 |
| 137 | protein localization to synapse (GO:0035418) | 2.63628625 |
| 138 | protein insertion into membrane (GO:0051205) | 2.60780015 |
| 139 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.56501240 |
| 140 | phagosome maturation (GO:0090382) | 2.56332655 |
| 141 | ferric iron transport (GO:0015682) | 2.54393224 |
| 142 | trivalent inorganic cation transport (GO:0072512) | 2.54393224 |
| 143 | negative regulation of appetite (GO:0032099) | 2.51550576 |
| 144 | negative regulation of response to food (GO:0032096) | 2.51550576 |
| 145 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.51392009 |
| 146 | vesicle docking (GO:0048278) | 2.50307677 |
| 147 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.49403374 |
| 148 | acidic amino acid transport (GO:0015800) | 2.48947916 |
| 149 | vesicle docking involved in exocytosis (GO:0006904) | 2.46529084 |
| 150 | glycosphingolipid biosynthetic process (GO:0006688) | 2.45553067 |
| 151 | protein maturation by protein folding (GO:0022417) | 2.44745204 |
| 152 | metallo-sulfur cluster assembly (GO:0031163) | 2.43995597 |
| 153 | iron-sulfur cluster assembly (GO:0016226) | 2.43995597 |
| 154 | actin nucleation (GO:0045010) | 2.43709764 |
| 155 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.42935923 |
| 156 | L-serine transport (GO:0015825) | 2.40805860 |
| 157 | neurofilament cytoskeleton organization (GO:0060052) | 2.40496842 |
| 158 | dosage compensation (GO:0007549) | 2.38935789 |
| 159 | sequestering of actin monomers (GO:0042989) | 2.38699340 |
| 160 | synaptic transmission, glutamatergic (GO:0035249) | 2.38124716 |
| 161 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.38076375 |
| 162 | gamma-aminobutyric acid transport (GO:0015812) | 2.37971162 |
| 163 | vesicle targeting (GO:0006903) | 2.36542311 |
| 164 | regulation of neurotransmitter secretion (GO:0046928) | 2.36489751 |
| 165 | nucleobase catabolic process (GO:0046113) | 2.35109310 |
| 166 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.34782301 |
| 167 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.34259272 |
| 168 | positive regulation of TOR signaling (GO:0032008) | 2.33697969 |
| 169 | neutrophil activation involved in immune response (GO:0002283) | 2.30171453 |
| 170 | neuronal ion channel clustering (GO:0045161) | 2.30105410 |
| 171 | sodium ion export (GO:0071436) | 2.29398483 |
| 172 | substantia nigra development (GO:0021762) | 2.28804292 |
| 173 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.28703275 |
| 174 | response to redox state (GO:0051775) | 2.28383334 |
| 175 | melanosome transport (GO:0032402) | 2.28062214 |
| 176 | endoplasmic reticulum organization (GO:0007029) | 2.27761119 |
| 177 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.27681939 |
| 178 | pH reduction (GO:0045851) | 2.26394373 |
| 179 | dendritic spine organization (GO:0097061) | 2.26186411 |
| 180 | virion assembly (GO:0019068) | 2.25927681 |
| 181 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.25141589 |
| 182 | amino acid import (GO:0043090) | 2.24861660 |
| 183 | L-glutamate transport (GO:0015813) | 2.22257334 |
| 184 | ER overload response (GO:0006983) | 2.21754386 |
| 185 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.21747683 |
| 186 | neurotransmitter transport (GO:0006836) | 2.21711397 |
| 187 | regulation of actin nucleation (GO:0051125) | 2.21671913 |
| 188 | regulation of neurotransmitter transport (GO:0051588) | 2.21486864 |
| 189 | regulation of neurotransmitter levels (GO:0001505) | 2.20898434 |
| 190 | regulation of vacuole organization (GO:0044088) | 2.20714532 |
| 191 | growth hormone secretion (GO:0030252) | 2.19710864 |
| 192 | postsynaptic membrane organization (GO:0001941) | 2.19318994 |
| 193 | * autophagy (GO:0006914) | 2.18893131 |
| 194 | negative regulation of interleukin-17 production (GO:0032700) | 2.18733731 |
| 195 | regulation of receptor recycling (GO:0001919) | 2.18382757 |
| 196 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.18329654 |
| 197 | regulation of protein targeting to membrane (GO:0090313) | 2.16682671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.53615841 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.81825318 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.58209976 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.34738590 |
| 5 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 4.26711217 |
| 6 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 4.17061703 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.07465807 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.95422660 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.58575235 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36504656 |
| 11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.26789782 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.12202250 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.01266803 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.97098877 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.95176491 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.92148823 |
| 17 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.90140156 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.78365090 |
| 19 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.69795222 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.67546090 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.47269284 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.46625717 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.31205804 |
| 24 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.26151666 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.26006546 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.25953584 |
| 27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.25939775 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.23163544 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.18432279 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.17341218 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14910673 |
| 32 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.14313350 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.13288177 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12605428 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.12582154 |
| 36 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09107084 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.08320113 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05453760 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.04446042 |
| 40 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.03511006 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.03022991 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98370004 |
| 43 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97756476 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.97565286 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.83429838 |
| 46 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78601264 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76612481 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76108392 |
| 49 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.75798899 |
| 50 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75066832 |
| 51 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.70554755 |
| 52 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68308386 |
| 53 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.65417063 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.63762427 |
| 55 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63672648 |
| 56 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.61050954 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60494354 |
| 58 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60475182 |
| 59 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.59571848 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.59036179 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57386670 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.56152106 |
| 63 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.55873985 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54733529 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.53888753 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53599571 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48228643 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45748816 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42786870 |
| 70 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42606723 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41142305 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41112793 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37402855 |
| 74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36227497 |
| 75 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.34207209 |
| 76 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.32523735 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32392804 |
| 78 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.32118850 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31815097 |
| 80 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.31113330 |
| 81 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29742420 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29505711 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28306012 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27076830 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26626018 |
| 86 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.24742053 |
| 87 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24702261 |
| 88 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23266833 |
| 89 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22220350 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21527598 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21439812 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20283482 |
| 93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20071874 |
| 94 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.19912424 |
| 95 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.19629427 |
| 96 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.18572317 |
| 97 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18170440 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17758599 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17593365 |
| 100 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.15712948 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15137301 |
| 102 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.13014809 |
| 103 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12143134 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12055468 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10390602 |
| 106 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10112515 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08415922 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08349727 |
| 109 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.07487168 |
| 110 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07448172 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06771088 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06748338 |
| 113 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06560061 |
| 114 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06460292 |
| 115 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05390408 |
| 116 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01270178 |
| 117 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00757396 |
| 118 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.00268122 |
| 119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99942743 |
| 120 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99759411 |
| 121 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.99685561 |
| 122 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.99685561 |
| 123 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.99685561 |
| 124 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98217174 |
| 125 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97741062 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97316065 |
| 127 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96673956 |
| 128 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.96655916 |
| 129 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96539990 |
| 130 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95370660 |
| 131 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95015806 |
| 132 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94718903 |
| 133 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.93980712 |
| 134 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92647858 |
| 135 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91958077 |
| 136 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91515638 |
| 137 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.91429641 |
| 138 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90935265 |
| 139 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90592499 |
| 140 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.90376997 |
| 141 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.89898565 |
| 142 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89128091 |
| 143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88816157 |
| 144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88816157 |
| 145 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.87941331 |
| 146 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87454974 |
| 147 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87423925 |
| 148 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86832674 |
| 149 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.86499515 |
| 150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85092826 |
| 151 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84536108 |
| 152 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.84410064 |
| 153 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84329705 |
| 154 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84263583 |
| 155 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.83598614 |
| 156 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83188954 |
| 157 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.82784047 |
| 158 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82424661 |
| 159 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.81776224 |
| 160 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81592398 |
| 161 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.81534094 |
| 162 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80726717 |
| 163 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80578480 |
| 164 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80450597 |
| 165 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80293086 |
| 166 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.79990545 |
| 167 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79725004 |
| 168 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.79225863 |
| 169 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.78860624 |
| 170 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77582482 |
| 171 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.76017750 |
| 172 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75929855 |
| 173 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.75407282 |
| 174 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.74900104 |
| 175 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.74413272 |
| 176 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.74341214 |
| 177 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.72519786 |
| 178 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72221569 |
| 179 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.71459296 |
| 180 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.69342999 |
| 181 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.68458488 |
| 182 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.64830222 |
| 183 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64786168 |
| 184 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.64138367 |
| 185 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.62839450 |
| 186 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62469151 |
| 187 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.62070347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.32046829 |
| 2 | MP0008260_abnormal_autophagy | 5.65919739 |
| 3 | MP0003718_maternal_effect | 5.28264713 |
| 4 | MP0003111_abnormal_nucleus_morphology | 4.26056420 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.89526300 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.83450261 |
| 7 | MP0003880_abnormal_central_pattern | 3.35509800 |
| 8 | MP0003786_premature_aging | 3.12627254 |
| 9 | MP0003077_abnormal_cell_cycle | 2.97320601 |
| 10 | MP0008058_abnormal_DNA_repair | 2.75806942 |
| 11 | MP0004270_analgesia | 2.65678262 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.63765361 |
| 13 | MP0001542_abnormal_bone_strength | 2.54952730 |
| 14 | MP0008932_abnormal_embryonic_tissue | 2.39169464 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.34171751 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.22796329 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.22256916 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.21606723 |
| 19 | MP0009840_abnormal_foam_cell | 2.17507712 |
| 20 | MP0004510_myositis | 2.15180223 |
| 21 | MP0003315_abnormal_perineum_morphology | 2.10196171 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.09645222 |
| 23 | MP0002064_seizures | 2.04886751 |
| 24 | MP0005395_other_phenotype | 2.03391335 |
| 25 | MP0003123_paternal_imprinting | 2.03021996 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.02499555 |
| 27 | MP0001661_extended_life_span | 2.01128126 |
| 28 | MP0003878_abnormal_ear_physiology | 1.91451154 |
| 29 | MP0005377_hearing/vestibular/ear_phenot | 1.91451154 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.87944195 |
| 31 | MP0003724_increased_susceptibility_to | 1.87494724 |
| 32 | MP0009745_abnormal_behavioral_response | 1.80936259 |
| 33 | MP0003646_muscle_fatigue | 1.76637438 |
| 34 | MP0002272_abnormal_nervous_system | 1.76536829 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.75810754 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.71655072 |
| 37 | MP0002572_abnormal_emotion/affect_behav | 1.69672591 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.67988987 |
| 39 | MP0008057_abnormal_DNA_replication | 1.63708239 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.62527307 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.62016778 |
| 42 | MP0001970_abnormal_pain_threshold | 1.60159605 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.58167574 |
| 44 | MP0001730_embryonic_growth_arrest | 1.57683586 |
| 45 | MP0005499_abnormal_olfactory_system | 1.56622233 |
| 46 | MP0005394_taste/olfaction_phenotype | 1.56622233 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.55580702 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.53631819 |
| 49 | MP0001486_abnormal_startle_reflex | 1.50699420 |
| 50 | MP0000343_altered_response_to | 1.48756569 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.47063489 |
| 52 | MP0005389_reproductive_system_phenotype | 1.45520999 |
| 53 | MP0002736_abnormal_nociception_after | 1.45326989 |
| 54 | MP0001984_abnormal_olfaction | 1.43476506 |
| 55 | MP0002160_abnormal_reproductive_system | 1.41819906 |
| 56 | MP0003879_abnormal_hair_cell | 1.41782227 |
| 57 | MP0003122_maternal_imprinting | 1.40630524 |
| 58 | MP0002822_catalepsy | 1.40289487 |
| 59 | MP0003941_abnormal_skin_development | 1.39922241 |
| 60 | MP0004484_altered_response_of | 1.37589057 |
| 61 | MP0008569_lethality_at_weaning | 1.34998394 |
| 62 | MP0004142_abnormal_muscle_tone | 1.33599325 |
| 63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.33126701 |
| 64 | MP0001502_abnormal_circadian_rhythm | 1.32349075 |
| 65 | MP0000604_amyloidosis | 1.31752852 |
| 66 | MP0005451_abnormal_body_composition | 1.30798051 |
| 67 | MP0003011_delayed_dark_adaptation | 1.30756302 |
| 68 | MP0001756_abnormal_urination | 1.30704914 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.29403524 |
| 70 | MP0003938_abnormal_ear_development | 1.29385356 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.29194679 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.26270747 |
| 73 | MP0002067_abnormal_sensory_capabilities | 1.25374769 |
| 74 | MP0003633_abnormal_nervous_system | 1.23764902 |
| 75 | MP0000920_abnormal_myelination | 1.23671208 |
| 76 | MP0008004_abnormal_stomach_pH | 1.23509629 |
| 77 | MP0001905_abnormal_dopamine_level | 1.23420349 |
| 78 | MP0002210_abnormal_sex_determination | 1.23292781 |
| 79 | MP0008874_decreased_physiological_sensi | 1.20900053 |
| 80 | MP0002132_abnormal_respiratory_system | 1.20497861 |
| 81 | MP0009764_decreased_sensitivity_to | 1.19608837 |
| 82 | MP0003186_abnormal_redox_activity | 1.19508953 |
| 83 | MP0001764_abnormal_homeostasis | 1.15566461 |
| 84 | MP0000350_abnormal_cell_proliferation | 1.13306620 |
| 85 | MP0002163_abnormal_gland_morphology | 1.13269500 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 1.12668797 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 1.12625704 |
| 88 | MP0005058_abnormal_lysosome_morphology | 1.11816922 |
| 89 | MP0006054_spinal_hemorrhage | 1.11348296 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 1.11125404 |
| 91 | MP0000358_abnormal_cell_content/ | 1.10474635 |
| 92 | MP0001672_abnormal_embryogenesis/_devel | 1.08916885 |
| 93 | MP0005380_embryogenesis_phenotype | 1.08916885 |
| 94 | MP0002229_neurodegeneration | 1.07405157 |
| 95 | MP0001145_abnormal_male_reproductive | 1.06628686 |
| 96 | MP0001727_abnormal_embryo_implantation | 1.06296841 |
| 97 | MP0003136_yellow_coat_color | 1.05613375 |
| 98 | MP0004924_abnormal_behavior | 1.05094127 |
| 99 | MP0005386_behavior/neurological_phenoty | 1.05094127 |
| 100 | MP0001919_abnormal_reproductive_system | 1.04519448 |
| 101 | MP0003567_abnormal_fetal_cardiomyocyte | 1.04257428 |
| 102 | MP0002396_abnormal_hematopoietic_system | 1.03058031 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 1.01573806 |
| 104 | MP0005083_abnormal_biliary_tract | 1.01528901 |
| 105 | MP0002080_prenatal_lethality | 1.01253942 |
| 106 | MP0001929_abnormal_gametogenesis | 1.01195798 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 1.00789720 |
| 108 | MP0005535_abnormal_body_temperature | 1.00468902 |
| 109 | MP0000749_muscle_degeneration | 0.99947962 |
| 110 | MP0003075_altered_response_to | 0.99728099 |
| 111 | MP0002557_abnormal_social/conspecific_i | 0.98888611 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.97153429 |
| 113 | MP0003303_peritoneal_inflammation | 0.96270749 |
| 114 | MP0006082_CNS_inflammation | 0.95458773 |
| 115 | MP0000653_abnormal_sex_gland | 0.95166594 |
| 116 | MP0002882_abnormal_neuron_morphology | 0.94927187 |
| 117 | MP0003631_nervous_system_phenotype | 0.94789216 |
| 118 | MP0000372_irregular_coat_pigmentation | 0.92852209 |
| 119 | MP0000647_abnormal_sebaceous_gland | 0.91944517 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.91730117 |
| 121 | MP0002972_abnormal_cardiac_muscle | 0.90611298 |
| 122 | MP0000747_muscle_weakness | 0.90305820 |
| 123 | MP0002653_abnormal_ependyma_morphology | 0.90172710 |
| 124 | MP0003984_embryonic_growth_retardation | 0.89994405 |
| 125 | MP0003690_abnormal_glial_cell | 0.89615584 |
| 126 | MP0001529_abnormal_vocalization | 0.89564797 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.88978005 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.88635353 |
| 129 | MP0002088_abnormal_embryonic_growth/wei | 0.86753443 |
| 130 | MP0000313_abnormal_cell_death | 0.85609287 |
| 131 | MP0005332_abnormal_amino_acid | 0.85514508 |
| 132 | MP0008789_abnormal_olfactory_epithelium | 0.84874046 |
| 133 | MP0003329_amyloid_beta_deposits | 0.83720993 |
| 134 | MP0002102_abnormal_ear_morphology | 0.83083899 |
| 135 | MP0003828_pulmonary_edema | 0.82179861 |
| 136 | MP0003656_abnormal_erythrocyte_physiolo | 0.82038119 |
| 137 | MP0005384_cellular_phenotype | 0.81717463 |
| 138 | MP0000627_abnormal_mammary_gland | 0.81053112 |
| 139 | MP0000955_abnormal_spinal_cord | 0.79735543 |
| 140 | MP0009697_abnormal_copulation | 0.79592588 |
| 141 | MP0000778_abnormal_nervous_system | 0.78816898 |
| 142 | MP0001697_abnormal_embryo_size | 0.78783670 |
| 143 | MP0001188_hyperpigmentation | 0.78732201 |
| 144 | MP0005621_abnormal_cell_physiology | 0.78709319 |
| 145 | MP0001440_abnormal_grooming_behavior | 0.77145301 |
| 146 | MP0002909_abnormal_adrenal_gland | 0.76296542 |
| 147 | MP0009046_muscle_twitch | 0.76234329 |
| 148 | MP0005620_abnormal_muscle_contractility | 0.75824406 |
| 149 | MP0002734_abnormal_mechanical_nocicepti | 0.75266681 |
| 150 | MP0005410_abnormal_fertilization | 0.74845766 |
| 151 | MP0001485_abnormal_pinna_reflex | 0.74074563 |
| 152 | MP0002269_muscular_atrophy | 0.70099333 |
| 153 | MP0001119_abnormal_female_reproductive | 0.69494343 |
| 154 | MP0003634_abnormal_glial_cell | 0.69429908 |
| 155 | MP0009763_increased_sensitivity_to | 0.68966684 |
| 156 | MP0005646_abnormal_pituitary_gland | 0.68900112 |
| 157 | MP0005164_abnormal_response_to | 0.68843378 |
| 158 | MP0000751_myopathy | 0.68713829 |
| 159 | MP0003279_aneurysm | 0.68476965 |
| 160 | MP0002735_abnormal_chemical_nociception | 0.67734259 |
| 161 | MP0005397_hematopoietic_system_phenotyp | 0.67553950 |
| 162 | MP0001545_abnormal_hematopoietic_system | 0.67553950 |
| 163 | MP0002277_abnormal_respiratory_mucosa | 0.67283815 |
| 164 | MP0009672_abnormal_birth_weight | 0.67082947 |
| 165 | MP0000681_abnormal_thyroid_gland | 0.66654392 |
| 166 | MP0005670_abnormal_white_adipose | 0.66454746 |
| 167 | MP0003698_abnormal_male_reproductive | 0.64290383 |
| 168 | MP0003699_abnormal_female_reproductive | 0.63794387 |
| 169 | MP0006292_abnormal_olfactory_placode | 0.61363837 |
| 170 | MP0002161_abnormal_fertility/fecundity | 0.61244781 |
| 171 | MP0005075_abnormal_melanosome_morpholog | 0.60314554 |
| 172 | MP0003195_calcinosis | 0.58675133 |
| 173 | MP0008995_early_reproductive_senescence | 0.58259016 |
| 174 | MP0002085_abnormal_embryonic_tissue | 0.57664275 |
| 175 | MP0003936_abnormal_reproductive_system | 0.56931528 |
| 176 | MP0004147_increased_porphyrin_level | 0.55409511 |
| 177 | MP0006276_abnormal_autonomic_nervous | 0.54874055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 5.52568041 |
| 2 | Breast hypoplasia (HP:0003187) | 5.06505412 |
| 3 | Upper limb muscle weakness (HP:0003484) | 4.82757925 |
| 4 | Polyphagia (HP:0002591) | 4.80732672 |
| 5 | Birth length less than 3rd percentile (HP:0003561) | 4.72561354 |
| 6 | Carpal bone hypoplasia (HP:0001498) | 4.66309382 |
| 7 | Hyperglycinemia (HP:0002154) | 4.28139144 |
| 8 | Rough bone trabeculation (HP:0100670) | 4.25382929 |
| 9 | Myokymia (HP:0002411) | 3.71626584 |
| 10 | Abnormality of alanine metabolism (HP:0010916) | 3.71292205 |
| 11 | Hyperalaninemia (HP:0003348) | 3.71292205 |
| 12 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.71292205 |
| 13 | Mutism (HP:0002300) | 3.69626349 |
| 14 | Abnormal eating behavior (HP:0100738) | 3.62284729 |
| 15 | Hand muscle atrophy (HP:0009130) | 3.53050581 |
| 16 | Secondary amenorrhea (HP:0000869) | 3.45808427 |
| 17 | Hyperglycinuria (HP:0003108) | 3.45788253 |
| 18 | Ankle clonus (HP:0011448) | 3.33282220 |
| 19 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.33225323 |
| 20 | CNS hypomyelination (HP:0003429) | 3.32768462 |
| 21 | Impulsivity (HP:0100710) | 3.32245809 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.28334786 |
| 23 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 3.24925605 |
| 24 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.23734829 |
| 25 | Abnormality of the umbilical cord (HP:0010881) | 3.21036036 |
| 26 | Delusions (HP:0000746) | 3.18955425 |
| 27 | Tetraparesis (HP:0002273) | 3.13356027 |
| 28 | Patellar aplasia (HP:0006443) | 3.13275302 |
| 29 | Abnormal trabecular bone morphology (HP:0100671) | 3.12264482 |
| 30 | Diplopia (HP:0000651) | 3.11695419 |
| 31 | Abnormality of binocular vision (HP:0011514) | 3.11695419 |
| 32 | Progressive muscle weakness (HP:0003323) | 3.06493103 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05649548 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05649548 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05649548 |
| 36 | Gout (HP:0001997) | 3.03723862 |
| 37 | Ureteral duplication (HP:0000073) | 3.00348124 |
| 38 | Distal upper limb amyotrophy (HP:0007149) | 2.94428753 |
| 39 | Upper limb amyotrophy (HP:0009129) | 2.94428753 |
| 40 | Atonic seizures (HP:0010819) | 2.93574386 |
| 41 | Spastic gait (HP:0002064) | 2.93469501 |
| 42 | 3-Methylglutaconic aciduria (HP:0003535) | 2.92397283 |
| 43 | Premature ovarian failure (HP:0008209) | 2.89312816 |
| 44 | Exercise-induced muscle cramps (HP:0003710) | 2.89176218 |
| 45 | Failure to thrive in infancy (HP:0001531) | 2.85740405 |
| 46 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.84152182 |
| 47 | Death in infancy (HP:0001522) | 2.82445792 |
| 48 | Limb dystonia (HP:0002451) | 2.82244725 |
| 49 | Neuronal loss in central nervous system (HP:0002529) | 2.81256236 |
| 50 | Petechiae (HP:0000967) | 2.76723329 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.76427967 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76427967 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.76217196 |
| 54 | Cholecystitis (HP:0001082) | 2.76217196 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.75677192 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.73840219 |
| 57 | Degeneration of anterior horn cells (HP:0002398) | 2.72910131 |
| 58 | Abnormality of the anterior horn cell (HP:0006802) | 2.72910131 |
| 59 | Glucose intolerance (HP:0000833) | 2.72639716 |
| 60 | Areflexia of lower limbs (HP:0002522) | 2.72106933 |
| 61 | Multiple enchondromatosis (HP:0005701) | 2.71559288 |
| 62 | Prolonged neonatal jaundice (HP:0006579) | 2.69614578 |
| 63 | Entropion (HP:0000621) | 2.68806970 |
| 64 | CNS demyelination (HP:0007305) | 2.68445072 |
| 65 | Dysautonomia (HP:0002459) | 2.67683959 |
| 66 | Loss of speech (HP:0002371) | 2.62677815 |
| 67 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.60881385 |
| 68 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.60255970 |
| 69 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.60255970 |
| 70 | Sparse eyelashes (HP:0000653) | 2.59864768 |
| 71 | Atrioventricular block (HP:0001678) | 2.56796859 |
| 72 | Testicular atrophy (HP:0000029) | 2.53540403 |
| 73 | Abnormal spermatogenesis (HP:0008669) | 2.53439802 |
| 74 | Congenital, generalized hypertrichosis (HP:0004540) | 2.51118902 |
| 75 | Progressive external ophthalmoplegia (HP:0000590) | 2.50822471 |
| 76 | Febrile seizures (HP:0002373) | 2.50229681 |
| 77 | Lower limb muscle weakness (HP:0007340) | 2.49185288 |
| 78 | Patent foramen ovale (HP:0001655) | 2.46597449 |
| 79 | Ventricular fibrillation (HP:0001663) | 2.46454818 |
| 80 | Absent hand (HP:0004050) | 2.46285352 |
| 81 | Irregular epiphyses (HP:0010582) | 2.45793383 |
| 82 | Epileptic encephalopathy (HP:0200134) | 2.45755748 |
| 83 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.43420232 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.42768690 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.41419470 |
| 86 | Unsteady gait (HP:0002317) | 2.39494115 |
| 87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.38711736 |
| 88 | Bundle branch block (HP:0011710) | 2.37685935 |
| 89 | Purpura (HP:0000979) | 2.37376325 |
| 90 | Muscle fiber splitting (HP:0003555) | 2.36142294 |
| 91 | Absent radius (HP:0003974) | 2.35986185 |
| 92 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.35545732 |
| 93 | Abnormality of the labia minora (HP:0012880) | 2.35133165 |
| 94 | Gait imbalance (HP:0002141) | 2.33492090 |
| 95 | Spastic tetraplegia (HP:0002510) | 2.32900790 |
| 96 | Menorrhagia (HP:0000132) | 2.31885453 |
| 97 | External ophthalmoplegia (HP:0000544) | 2.30929944 |
| 98 | Peripheral hypomyelination (HP:0007182) | 2.30022830 |
| 99 | Postnatal microcephaly (HP:0005484) | 2.29515824 |
| 100 | Microretrognathia (HP:0000308) | 2.29286220 |
| 101 | Focal motor seizures (HP:0011153) | 2.29044777 |
| 102 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.28892359 |
| 103 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.28573207 |
| 104 | Focal dystonia (HP:0004373) | 2.27132544 |
| 105 | Hepatic necrosis (HP:0002605) | 2.26250029 |
| 106 | Hepatocellular necrosis (HP:0001404) | 2.25149647 |
| 107 | Amyotrophic lateral sclerosis (HP:0007354) | 2.24151319 |
| 108 | Megaloblastic anemia (HP:0001889) | 2.23795696 |
| 109 | Torticollis (HP:0000473) | 2.23610843 |
| 110 | Diminished motivation (HP:0000745) | 2.22961091 |
| 111 | Increased serum lactate (HP:0002151) | 2.22240360 |
| 112 | Action tremor (HP:0002345) | 2.21728900 |
| 113 | Personality changes (HP:0000751) | 2.21524392 |
| 114 | Aplasia involving forearm bones (HP:0009822) | 2.21354341 |
| 115 | Absent forearm bone (HP:0003953) | 2.21354341 |
| 116 | Pancreatic fibrosis (HP:0100732) | 2.21242285 |
| 117 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.21227601 |
| 118 | Hypsarrhythmia (HP:0002521) | 2.20878471 |
| 119 | Autoamputation (HP:0001218) | 2.20460991 |
| 120 | Tongue fasciculations (HP:0001308) | 2.20354315 |
| 121 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18362063 |
| 122 | Craniofacial dystonia (HP:0012179) | 2.15666468 |
| 123 | Epileptiform EEG discharges (HP:0011182) | 2.15399802 |
| 124 | Abnormality of glycolysis (HP:0004366) | 2.15274054 |
| 125 | Increased serum pyruvate (HP:0003542) | 2.15274054 |
| 126 | Split foot (HP:0001839) | 2.14852300 |
| 127 | Medial flaring of the eyebrow (HP:0010747) | 2.14550722 |
| 128 | Tetraplegia (HP:0002445) | 2.11482466 |
| 129 | Type 2 muscle fiber atrophy (HP:0003554) | 2.10676504 |
| 130 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.10612561 |
| 131 | Myoglobinuria (HP:0002913) | 2.08917889 |
| 132 | Rapidly progressive (HP:0003678) | 2.08547096 |
| 133 | Submucous cleft hard palate (HP:0000176) | 2.08054663 |
| 134 | Muscle fibrillation (HP:0010546) | 2.06133004 |
| 135 | Fetal akinesia sequence (HP:0001989) | 2.05015153 |
| 136 | Nausea (HP:0002018) | 2.03901744 |
| 137 | Apathy (HP:0000741) | 2.03230597 |
| 138 | Cerebral inclusion bodies (HP:0100314) | 2.02375409 |
| 139 | Spinal muscular atrophy (HP:0007269) | 2.01698414 |
| 140 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.01448478 |
| 141 | Oral leukoplakia (HP:0002745) | 2.01166526 |
| 142 | Congenital primary aphakia (HP:0007707) | 2.00939302 |
| 143 | Poor suck (HP:0002033) | 2.00339116 |
| 144 | Focal seizures (HP:0007359) | 1.99839635 |
| 145 | Nephrogenic diabetes insipidus (HP:0009806) | 1.99697356 |
| 146 | Increased CSF lactate (HP:0002490) | 1.99245569 |
| 147 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.99190537 |
| 148 | Short tibia (HP:0005736) | 1.98946274 |
| 149 | Bone marrow hypocellularity (HP:0005528) | 1.98301549 |
| 150 | Long foot (HP:0001833) | 1.98070318 |
| 151 | Increased mean platelet volume (HP:0011877) | 1.95720795 |
| 152 | Short nail (HP:0001799) | 1.95189356 |
| 153 | Meckel diverticulum (HP:0002245) | 1.95179222 |
| 154 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95031211 |
| 155 | Hemiparesis (HP:0001269) | 1.94738591 |
| 156 | Mitochondrial inheritance (HP:0001427) | 1.93711359 |
| 157 | Azoospermia (HP:0000027) | 1.93244971 |
| 158 | Dysostosis multiplex (HP:0000943) | 1.92830109 |
| 159 | Brittle hair (HP:0002299) | 1.92224724 |
| 160 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.92100374 |
| 161 | Stomach cancer (HP:0012126) | 1.90664461 |
| 162 | Neonatal respiratory distress (HP:0002643) | 1.90625666 |
| 163 | Spastic paraparesis (HP:0002313) | 1.90411169 |
| 164 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.89860333 |
| 165 | Aplasia of the musculature (HP:0100854) | 1.89050262 |
| 166 | Premature graying of hair (HP:0002216) | 1.88873106 |
| 167 | Gingival bleeding (HP:0000225) | 1.88074447 |
| 168 | Increased serum ferritin (HP:0003281) | 1.87780398 |
| 169 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.87693735 |
| 170 | Absent epiphyses (HP:0010577) | 1.87693735 |
| 171 | Lethargy (HP:0001254) | 1.87413356 |
| 172 | Generalized tonic-clonic seizures (HP:0002069) | 1.87072272 |
| 173 | Trismus (HP:0000211) | 1.86959024 |
| 174 | Urinary urgency (HP:0000012) | 1.85764095 |
| 175 | Abnormal neuron morphology (HP:0012757) | 1.85508776 |
| 176 | Abnormality of the motor neurons (HP:0002450) | 1.85508776 |
| 177 | Agitation (HP:0000713) | 1.85373782 |
| 178 | Emotional lability (HP:0000712) | 1.85198774 |
| 179 | Vacuolated lymphocytes (HP:0001922) | 1.82989790 |
| 180 | Hammertoe (HP:0001765) | 1.82921040 |
| 181 | Generalized aminoaciduria (HP:0002909) | 1.81921023 |
| 182 | Intention tremor (HP:0002080) | 1.81414343 |
| 183 | Rhabdomyolysis (HP:0003201) | 1.81192709 |
| 184 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.80590251 |
| 185 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.80590251 |
| 186 | Abnormal platelet volume (HP:0011876) | 1.79977093 |
| 187 | Metaphyseal dysplasia (HP:0100255) | 1.79427843 |
| 188 | Bradykinesia (HP:0002067) | 1.75692458 |
| 189 | Epistaxis (HP:0000421) | 1.73031161 |
| 190 | Specific learning disability (HP:0001328) | 1.71121634 |
| 191 | Episodic fever (HP:0001954) | 1.71102459 |
| 192 | Anxiety (HP:0000739) | 1.69697094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.94787471 |
| 2 | WEE1 | 4.34431050 |
| 3 | TSSK6 | 3.98097613 |
| 4 | PLK4 | 3.97787023 |
| 5 | STK16 | 3.80625173 |
| 6 | AKT3 | 3.49357520 |
| 7 | IRAK3 | 3.24801869 |
| 8 | TESK1 | 3.10358078 |
| 9 | EIF2AK1 | 2.92781767 |
| 10 | EPHA2 | 2.67775327 |
| 11 | LIMK1 | 2.67059862 |
| 12 | ZAK | 2.66178798 |
| 13 | PNCK | 2.64193878 |
| 14 | SRPK1 | 2.47643604 |
| 15 | TRIM28 | 1.98675831 |
| 16 | SIK3 | 1.98408181 |
| 17 | ARAF | 1.97916912 |
| 18 | PLK3 | 1.97434365 |
| 19 | PAK6 | 1.94921047 |
| 20 | EIF2AK3 | 1.83387529 |
| 21 | MAP2K7 | 1.80672847 |
| 22 | MAP4K2 | 1.76752511 |
| 23 | BRSK2 | 1.74825146 |
| 24 | PINK1 | 1.69601594 |
| 25 | MAP3K5 | 1.66519582 |
| 26 | PIM2 | 1.62973617 |
| 27 | NME1 | 1.60940295 |
| 28 | MARK1 | 1.59533149 |
| 29 | NEK1 | 1.58407126 |
| 30 | NME2 | 1.57689676 |
| 31 | PHKG1 | 1.57098237 |
| 32 | PHKG2 | 1.57098237 |
| 33 | MAP3K4 | 1.53500222 |
| 34 | DAPK2 | 1.52689279 |
| 35 | CCNB1 | 1.51859233 |
| 36 | TTK | 1.50422432 |
| 37 | PDK4 | 1.46077029 |
| 38 | PDK3 | 1.46077029 |
| 39 | EPHA3 | 1.43889059 |
| 40 | DYRK1B | 1.43107108 |
| 41 | PLK1 | 1.39662924 |
| 42 | MAP3K11 | 1.36251784 |
| 43 | PDK2 | 1.36216639 |
| 44 | MINK1 | 1.35733924 |
| 45 | BRAF | 1.34811144 |
| 46 | BRSK1 | 1.29047082 |
| 47 | MKNK2 | 1.23869770 |
| 48 | PAK3 | 1.22752066 |
| 49 | DYRK3 | 1.19658727 |
| 50 | ACVR1B | 1.18191450 |
| 51 | GRK7 | 1.15467370 |
| 52 | NEK2 | 1.11511467 |
| 53 | ERBB3 | 1.11411726 |
| 54 | TAOK2 | 1.09694960 |
| 55 | STK38L | 1.09388393 |
| 56 | CDK14 | 1.08223838 |
| 57 | IRAK2 | 1.08167397 |
| 58 | IRAK4 | 1.06994812 |
| 59 | RIPK4 | 1.05674844 |
| 60 | VRK1 | 1.04094185 |
| 61 | UHMK1 | 1.03082287 |
| 62 | MKNK1 | 1.02334119 |
| 63 | DYRK2 | 1.00717474 |
| 64 | PTK2B | 0.97908120 |
| 65 | MAP2K4 | 0.97162923 |
| 66 | EPHB1 | 0.95550347 |
| 67 | MOS | 0.94882180 |
| 68 | MAPK13 | 0.93263774 |
| 69 | TESK2 | 0.92813611 |
| 70 | AURKA | 0.92020709 |
| 71 | PRKCI | 0.90943339 |
| 72 | CDK5 | 0.89812642 |
| 73 | LMTK2 | 0.89608299 |
| 74 | KSR1 | 0.89129505 |
| 75 | NTRK1 | 0.88110358 |
| 76 | EPHA4 | 0.87405931 |
| 77 | NTRK3 | 0.85020957 |
| 78 | CASK | 0.83569147 |
| 79 | TAOK3 | 0.83405050 |
| 80 | DYRK1A | 0.82865033 |
| 81 | STK24 | 0.82231730 |
| 82 | CDK18 | 0.79777895 |
| 83 | CAMK2A | 0.79358629 |
| 84 | KSR2 | 0.78855093 |
| 85 | CHEK2 | 0.77496821 |
| 86 | TBK1 | 0.76985328 |
| 87 | AURKB | 0.75472826 |
| 88 | SIK2 | 0.73007689 |
| 89 | EIF2AK2 | 0.71967532 |
| 90 | CDK15 | 0.71711349 |
| 91 | IRAK1 | 0.70353252 |
| 92 | CDK11A | 0.68752839 |
| 93 | DAPK3 | 0.67532091 |
| 94 | MAP3K9 | 0.62056801 |
| 95 | ABL2 | 0.61934590 |
| 96 | TAOK1 | 0.61643631 |
| 97 | OBSCN | 0.59827303 |
| 98 | PKN1 | 0.59357818 |
| 99 | LATS2 | 0.58360504 |
| 100 | NTRK2 | 0.57454017 |
| 101 | MAPK12 | 0.56968906 |
| 102 | PRKCG | 0.55041592 |
| 103 | BMX | 0.51144138 |
| 104 | CSNK2A1 | 0.51056229 |
| 105 | MATK | 0.51006830 |
| 106 | PRKD1 | 0.50682486 |
| 107 | PAK1 | 0.48718260 |
| 108 | CAMKK2 | 0.48093623 |
| 109 | BCR | 0.47433563 |
| 110 | CSNK1G3 | 0.46918013 |
| 111 | JAK2 | 0.46120205 |
| 112 | KDR | 0.46066862 |
| 113 | NEK6 | 0.44520015 |
| 114 | CDK19 | 0.43868981 |
| 115 | FER | 0.43819957 |
| 116 | MAP3K12 | 0.42963434 |
| 117 | CAMK2G | 0.42789735 |
| 118 | PLK2 | 0.42732092 |
| 119 | BCKDK | 0.41507533 |
| 120 | NUAK1 | 0.41429383 |
| 121 | MAP3K6 | 0.41419605 |
| 122 | FES | 0.38893250 |
| 123 | CSNK2A2 | 0.38408984 |
| 124 | MAP3K3 | 0.37673585 |
| 125 | EPHB2 | 0.37292795 |
| 126 | SYK | 0.37260845 |
| 127 | PIK3CG | 0.36776448 |
| 128 | ILK | 0.36203179 |
| 129 | MARK2 | 0.34959162 |
| 130 | CDK3 | 0.34743613 |
| 131 | STK38 | 0.34117094 |
| 132 | CHEK1 | 0.32954127 |
| 133 | RPS6KA5 | 0.32930385 |
| 134 | GRK6 | 0.32552200 |
| 135 | ADRBK1 | 0.32340208 |
| 136 | TLK1 | 0.31897680 |
| 137 | MST4 | 0.29919685 |
| 138 | CAMK2B | 0.29392908 |
| 139 | ATR | 0.29094667 |
| 140 | STK3 | 0.28875592 |
| 141 | CSNK1E | 0.28661301 |
| 142 | CSNK1A1 | 0.28316715 |
| 143 | WNK3 | 0.28056579 |
| 144 | PIM1 | 0.27983563 |
| 145 | ALK | 0.26402366 |
| 146 | CSNK1G1 | 0.24065834 |
| 147 | CDK2 | 0.23949308 |
| 148 | GRK1 | 0.23581322 |
| 149 | GRK5 | 0.22890769 |
| 150 | OXSR1 | 0.22017811 |
| 151 | PRKCE | 0.20707945 |
| 152 | PAK4 | 0.20169353 |
| 153 | MAP3K8 | 0.19610490 |
| 154 | CDK1 | 0.18416705 |
| 155 | CDK7 | 0.17863414 |
| 156 | BMPR2 | 0.17764683 |
| 157 | CAMK2D | 0.17549299 |
| 158 | CSNK1G2 | 0.17280249 |
| 159 | CSNK1A1L | 0.16239074 |
| 160 | RAF1 | 0.14932830 |
| 161 | RPS6KA4 | 0.13193549 |
| 162 | MYLK | 0.12034848 |
| 163 | IKBKB | 0.11389758 |
| 164 | MAPK4 | 0.11141755 |
| 165 | RPS6KB2 | 0.09775853 |
| 166 | ADRBK2 | 0.09418791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.94736396 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.37096012 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 5.34060693 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.06009866 |
| 5 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.19617872 |
| 6 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.78226662 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.77780649 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.51543483 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.49316689 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.35353124 |
| 11 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.31887651 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.25170481 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.23076985 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 2.11961436 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.93854264 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.91313821 |
| 17 | Purine metabolism_Homo sapiens_hsa00230 | 1.89870859 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.79168490 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.75070389 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72685970 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68180445 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.68030826 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.65309966 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.60263364 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59812640 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.58434696 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.54757514 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.54197245 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50914620 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.48457623 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.48349872 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48246656 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.46425270 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.45415756 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44759024 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42894765 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.35841307 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.35361489 |
| 39 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.34317174 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31307598 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 1.29945866 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.28971936 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28947325 |
| 44 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.26091505 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24107964 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22943841 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22131411 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21031260 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11325479 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.09236883 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04242824 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01983832 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01277823 |
| 54 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97948098 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95586226 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 0.94611631 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92985424 |
| 58 | Protein export_Homo sapiens_hsa03060 | 0.91062213 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91058665 |
| 60 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.90181785 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.88929681 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86134388 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86130414 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.85236223 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 0.82244045 |
| 66 | Alcoholism_Homo sapiens_hsa05034 | 0.82024080 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.80262927 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.79079021 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76084251 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75674515 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75670399 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74341430 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72921230 |
| 74 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72585639 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.72514060 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71289630 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70404696 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.68469751 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.66530317 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.64435081 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64149796 |
| 82 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63753810 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63083578 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62961785 |
| 85 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62749396 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62601474 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60736018 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59613126 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59397095 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59340421 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.58321210 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.57769666 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57486348 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54744131 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53760606 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52959873 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52862230 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51543032 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51304838 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.50006570 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49952368 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.49911429 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49906723 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49697712 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.48918249 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47019828 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45128469 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.44328784 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44031703 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43746553 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41527416 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41488502 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41292085 |
| 114 | Axon guidance_Homo sapiens_hsa04360 | 0.39944673 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39729166 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39271770 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37605175 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37453461 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.35370656 |
| 120 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34800471 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34605020 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34051157 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33497026 |
| 124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32869829 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32331215 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31552739 |
| 127 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29675679 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28769818 |
| 129 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28459251 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26583197 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22743297 |
| 132 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.22066322 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21476858 |
| 134 | Phototransduction_Homo sapiens_hsa04744 | 0.21186899 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.19398000 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18917563 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.18611595 |
| 138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17417134 |
| 139 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16923465 |
| 140 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.15352297 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.13634924 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13147726 |
| 143 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.10714439 |
| 144 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.10525292 |
| 145 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10076528 |
| 146 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.07652917 |
| 147 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07487880 |
| 148 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.06897128 |
| 149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.06750350 |
| 150 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.04160111 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.01624378 |
| 152 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.00553147 |
| 153 | Legionellosis_Homo sapiens_hsa05134 | 0.00110188 |
| 154 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0254264 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0219441 |
| 156 | Shigellosis_Homo sapiens_hsa05131 | -0.0208995 |
| 157 | Endocytosis_Homo sapiens_hsa04144 | -0.0171027 |
| 158 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0044307 |
| 159 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0018588 |

